While some of the details are new, the report's authors acknowledge several of their ultimate findings stem from systemic problems known long before President Donald Trump took office.
Covid shots designed to protect against the omicron variant trigger a weaker immune response against the rapidly emerging BQ.1.1 subvariant than the previously dominant strain, according to a new lab study.
A study yesterday in JAMA Internal Medicine shows women and racial minorities were underrepresented in both COVID-19 clinical treatment trials and in disease prevention trials.
The research was conducted by a team from the Fred Hutchinson Cancer Center, as well researchers from Beijing and London.
..Global health officials cautioned the public against letting its guard down, while acknowledging a change in outlook nearly three years after the virus was first detected. The World Health Organization (WHO) has yet to declare an end to the COVID public health emergency introduced in January 2020.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/7LY2VV7YGBNE5AEH4WRN2FIOGU.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/UCLN33RRWBKBDC4E5AR6URYBZY.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/6EF6LNO5WJLR7MCFLP3PIXS3UU.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZTJKG6CUSZOZTEALSY3ACISC2Y.jpg)
Recent Comments